4.3 Letter

Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation

Journal

LEUKEMIA & LYMPHOMA
Volume 51, Issue 10, Pages 1941-1943

Publisher

INFORMA HEALTHCARE
DOI: 10.3109/10428194.2010.506567

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available